Blood test may predict lymphoma outcomes without scans
NCT ID NCT07480837
First seen Mar 23, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study looks at whether tracking tumor DNA in the blood (ctDNA) can help predict how well treatment works for people with B-cell non-Hodgkin lymphoma. Researchers will collect blood samples from 60 patients before and during treatment to see if changes in ctDNA levels match with standard imaging results. The goal is to find a simpler, less invasive way to monitor the disease and guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL NON HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Conditions
Explore the condition pages connected to this study.